Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Bridging the AI Chasm in Oncology: A Standardized Platform for In-Silico Clinical Validation of AI Models within the CHAIMELEON Project

  • Galiana-Bordera, Adrián
  • Aquerreta-Escribano, Javier
  • Martínez-Gironés, Pedro Miguel
  • Ribas, Gloria
  • Jiménez-Gómez, Paula
  • Marti-Bonmati, Luis
  • Lozano Lloret, Pau|||0000-0002-6143-5484
  • Segrelles Quilis, José Damián|||0000-0001-5698-7965
  • Cerdá-Alberich, Leonor
  • Blanquer Espert, Ignacio|||0000-0003-1692-8922
[EN] Objective: Artificial intelligence (AI) shows promise for improving cancer management, but clinical adoption is limited by the absence of standardized validation tools. As an important step toward bridging the AI chasm, the European CHAIMELEON project addresses this gap by developing a platform for in silico validation of AI models in oncology, aligned with the EUCAIM project. Materials and methods: We designed a web-based platform using Kubernetes microservices architecture, integrating imaging, clinical, and AI components. The backend combines a REST API, an ORTHANC-PACS, and a Keycloak/OAuth2 security layer. The frontend includes a customized OHIF DICOM viewer for oncological case review. Clinicians evaluated cases across three sequential stages: (1) Standard clinical assessment, (2) Assessment with AI predictions, and (3) Final review against clinical endpoint ground truth. The platform also collects clinicians' perceptions of AI utility, trust, workflow integration, and usability through a Likert-scale questionnaire. Results: The platform provided efficient access to multimodal data for five cancer types. Clinicians completed structured validations, and survey responses indicated favorable perceptions: 93% found the platform intuitive, over 80% would recommend it, and agreement on AI utility exceeded 40% across most endpoints, indicating a positive reception of the AI as a supportive "second reader" tool that prompts clinical re-evaluation rather than simple consensus. Workflow impact was rated positively, underlining the potential to support clinical decision-making. Conclusion: This platform offers a reproducible, scalable, and user-friendly environment for clinical validation of AI models in oncology. Its modular architecture allows integration of additional AI models and is designed to ensure sustainability and interoperability, fostering evidence-based AI adoption in European radiology practice., This research was supported by several grants, including European projects such as CHAIMELEON (GA: 952172; DOI: 10.3030/952172) and EUCAIM (GA: 101100633), both funded by the European Commission. These projects have collectively advanced the development and application of the platform and methodology described in this manuscript, facilitating its integration into national and European research platforms to enhance the validity and utility of medical AI models across various AI-driven healthcare studies.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Empowering cancer research in Europe: the EUCAIM cancer imaging infrastructure

  • Marti-Bonmati, Luis
  • Tsiknakis, Manolis
  • Tsakou, Gianna
  • Ricard Martínez Martínez
  • Capella Gutierrez, Salvador
  • Zullino, Sara
  • Mészáros, János
  • Bron, Esther E.
  • Gelpi, Jose Luis
  • Riklund, Katrine
  • Chaabane, Linda
  • Schlemmer, Heinz-Peter
  • Aznar, Mario
  • Serrano Candelas, Patricia
  • Gordebeke, P
  • Hierath, M
  • Blanquer Espert, Ignacio|||0000-0003-1692-8922
[EN] Artificial intelligence (AI) is a powerful technology with the potential to disrupt cancer detection, diagnosis and treatment. However, the development of new AI algorithms requires access to large and complex real-world datasets. Although such datasets are constantly being generated, access to them is limited by data fragmentation across numerous repositories and sites, heterogeneity, lack of annotations, and potential privacy issues. The European Cancer Imaging Initiative is a flagship of Europe's Beating Cancer Plan, aiming to unlock the power of AI for cancer patients, clinicians, and researchers by establishing a federated European infrastructure for cancer images through the EU-funded EUropean Federation for CAncer IMages (EUCAIM) project. This infrastructure, called Cancer Image Europe, builds on the AI for Health Imaging network (AI4HI), established European Research Infrastructures (Euro-BioImaging, BBMRI-ERIC, EATRIS, ECRIN, and ELIXIR), and numerous related partners providing access to research tools, images, and related clinical, pathology and molecular data.; The infrastructure targets clinicians, researchers, and innovators by providing the means to develop and validate data-intensive AI-based and other IT-enabled clinical decision-making systems supporting precision medicine. Common data models, including a linking hyperontology, quality standards, compliance with the FAIR (Findability, Accessibility, Interoperability and Reusability) principles, data annotation, curation and anonymization services are provided to ensure data quality and interoperability, consistency and privacy. In summer 2024, the EUCAIM project released the first prototype of an EU-wide infrastructure, with a comprehensive dashboard integrating applications for dataset discovery, federated search, data access request, metadata harvesting, annotation, secure processing environments and federated processing., EUCAIM is co-funded by the European Union under Grant Agreement 101100633. Views and opinions expressed are, however, those of the author(s) only and do not necessarily reflect those of the European Union or the European Commission. Neither the European Union nor the granting authority can be held responsible for them.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

How the First Medical Imaging Cancer Atlas EUCAIM Was Populated: The Experience of a Reference Hospital

  • Penadés Blasco, Ana
  • Cerda Alberich, Leonor
  • de Marco Garcia, Ana
  • Soler Pons, Carina
  • Marin, Irene
  • Ricard Martínez Martínez
  • Blanquer, Ignacio
  • Marti-Bonmati, Luis
  • Segrelles Quilis, José Damián|||0000-0001-5698-7965
[EN] The fragmentation and decentralization of medical data, including radiological imaging, continue to challenge large-scale observational research across Europe. Artificial intelligence (AI) applied to big datasets is transforming diagnosis and treatments towards precision medicine across many diseases, yet the lack of findable, accessible, and interoperable datasets still limits model development, validation, and final clinical translation. The European Federation for Cancer Images (EUCAIM) project was launched in 2023 to address these challenges by establishing a secure centralized and federated infrastructure for the secondary use of large-scale oncological imaging and related clinical data. By consolidating fragmented datasets, EUCAIM lays the groundwork for harmonized data governance and trusted cross-border sharing. Implementing a robust documentation framework is essential to ensure regulatory compliance, safeguard data integrity, and support secure data flows across institutional and national boundaries, fully aligned with European regulations and ethical standards. EUCAIM builds on the AI for Health Imaging (AI4HI) initiative (PRIMAGE, CHAIMELEON, EuCanImage, ProCancer-I, INCISIVE) and integrates over 94 partners and more than 180 stakeholders spanning medical imaging, high performance computing, data standardization, innovation, and legal compliance. This large collaborative ecosystem reinforces EUCAIM¿s role as a reference for General Data Protection Regulation (GDPR) and European Health Data Space Regulation (EHDSR) adherence. This publication presents the real-world experience of integrating imaging and clinical data from a reference university hospital into the EUCAIM infrastructure. It outlines the procedural, ethical, and legal challenges encountered, and details the strategies implemented to ensure compliance with data protection regulations, including privacy, security, and ethical standards. These insights offer a practical framework for future large-scale oncological imaging datasets harmonization and AI development, contributing to scalable, reproducible, and legally compliant research that strengthens Europe¿s capacity for trustworthy AI-driven oncology solutions., This project has received funding from the Digital Europe Programme (DIGITAL) under grant agreement No 101100633 (European Federation for Cancer Images [EUCAIM]).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Lessons Learned From European Health Data Projects With Cancer Use Cases: Implementation of Health Standards and Internet of Things Semantic Interoperability

  • Gyrard, Amelie
  • Abedian, Somayeh
  • Gribbon, Philip
  • Manias, George
  • van Nuland, Rick
  • Zatloukal, Kurt
  • Nicolae, Irina Emilia
  • Danciu, Gabriel
  • Nechifor, Septimiu
  • Marti-Bonmati, Luis
  • Mallol, Pedro
  • Dalmiani, Stefano
  • Autexier, Serge
  • Jendrossek, Mario
  • Avramidis, Ioannis
  • Blanquer Espert, Ignacio|||0000-0003-1692-8922
[EN] The adoption of the European Health Data Space (EHDS) regulation has made integrating health data critical for both primary and secondary applications. Primary use cases include patient diagnosis, prognosis, and treatment, while secondary applications support research, innovation, and regulatory decision-making. Additionally, leveraging large datasets improves training quality for artificial intelligence (AI) models, particularly in cancer prevention, prediction, and treatment personalization. The European related to fragmentation and the lack of standardization in metadata, data storage, access, and processing. This paper examines interoperability standards used in six EU-funded cancer-related projects: IDERHA (Integration of Heterogeneous Data and ASCAPE (Artificial Intelligence Supporting Cancer Patients Across Europe), iHelp, BigPicture, and the HealthData@EU pilot. These initiatives aim to enhance the analysis of heterogeneous health data while aligning with EHDS implementation, specifically for the EHDS for the secondary use of data (EHDS2). Between October 2023 and July 2024, we organized meetings and workshops among these projects to assess how they adopt health standards and apply Internet of Things (IoT) semantic interoperability. The discussions focused on interoperability standards for health data, knowledge graphs, the data quality framework, patient-generated health data, AI reasoning, federated approaches, security, and privacy. Based on our findings, we developed a template for designing the EHDS2 interoperability framework in alignment with the new European Interoperability Framework (EIF) and EHDS governance standards. This template maps EHDS2-recommended standards to the EIF model and principles, linking the proposed EHDS2 data quality framework to relevant International Organization for Standardization (ISO) standards. Using this template, we analyzed and compared how the recommended EHDS2 standards were implemented across the studied projects. During workshops, project teams shared insights on overcoming interoperability challenges and their innovative approaches to bridging gaps in standardization. With support from HSbooster.eu, we facilitated collaboration among these projects to exchange knowledge on standards, legal implementation, project sustainability, and harmonization with EHDS2. The findings from this work, including the created template and lessons learned, will be compiled into an interactive toolkit for the EHDS2 interoperability framework. This toolkit will help existing and future projects align with EHDS2 technical and legal requirements, serving as a foundation for a common EHDS2 interoperability framework. Additionally, standardization efforts include participation in the development of ISO/IEC 21823-3:2021-Semantic Interoperability for IoT Systems. Since no ISO standard currently exists for digital pathology and AI-based image analysis for medical diagnostics, the BigPicture project is contributing to ISO/PWI 24051-2, which focuses on digital pathology and AI-based, whole-slide image analysis. Integrating these efforts with ongoing ISO initiatives can enhance global standardization and facilitate widespread adoption across health care systems., AG declares funding from HSBOOSTER 101058391, StandICT.eu 2026 101091933. The IDERHA (Integration of Heterogeneous Data and Evidence Towards Regulatory and Health Technology Assessments Acceptance) project is supported by the Innovative Health Initiative (IHI) Joint Undertaking (JU) under grant agreement 101112135. The JU receives support from the European Union's Horizon Europe research and innovation program and life science industries represented by COCIR, EFPIA/Vaccines Europe, EuropaBio, and MedTech Europe. The BigPicture project has received funding from the Innovative Medicines Initiative 2 JU under grant agreement 945358. This JU receives support from the European Union's Horizon 2020 research and innovation program and EFPIA. The iHelp project received funding from the European Union's Horizon 2020 research and innovation program under grant agreement 101017441. The ASCAPE (Artificial Intelligence Supporting Cancer Patients Across Europe) project received funding from the European Union's Horizon 2020 research and innovation program under grant agreement No 875351. The EUCAIM (European Cancer Imaging Initiative) project is cofunded by the European Union under grant agreement 101100633. The HealthData@EU pilot is cofunded by the European Union.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Empowering cancer research in Europe: the EUCAIM cancer imaging infrastructure

  • Martí-Bonmatí, Luis
  • Blanquer, Ignacio
  • Capella, Salvador
  • EUCAIM Consortium European Society of Radiology
EUCAIM Consortium European Society of Radiology: et al., Artificial intelligence (AI) is a powerful technology with the potential to disrupt cancer detection, diagnosis and treatment. However, the development of new AI algorithms requires access to large and complex real-world datasets. Although such datasets are constantly being generated, access to them is limited by data fragmentation across numerous repositories and sites, heterogeneity, lack of annotations, and potential privacy issues. The European Cancer Imaging Initiative is a flagship of Europe’s Beating Cancer Plan, aiming to unlock the power of AI for cancer patients, clinicians, and researchers by establishing a federated European infrastructure for cancer images through the EU-funded EUropean Federation for CAncer IMages (EUCAIM) project. This infrastructure, called Cancer Image Europe, builds on the AI for Health Imaging network (AI4HI), established European Research Infrastructures (Euro-BioImaging, BBMRI-ERIC, EATRIS, ECRIN, and ELIXIR), and numerous related partners providing access to research tools, images, and related clinical, pathology and molecular data. The infrastructure targets clinicians, researchers, and innovators by providing the means to develop and validate data-intensive AI-based and other IT-enabled clinical decision-making systems supporting precision medicine. Common data models, including a linking hyperontology, quality standards, compliance with the FAIR (Findability, Accessibility, Interoperability and Reusability) principles, data annotation, curation and anonymization services are provided to ensure data quality and interoperability, consistency and privacy. In summer 2024, the EUCAIM project released the first prototype of an EU-wide infrastructure, with a comprehensive dashboard integrating applications for dataset discovery, federated search, data access request, metadata harvesting, annotation, secure processing environments and federated processing., [Critical relevance statement] EUCAIM’s federated infrastructure for cancer image data advances medical research and related AI development in Europe. It addresses the current fragmentation and heterogeneity of data repositories is legally compliant, and facilitates collaboration among clinicians, researchers, and innovators., EUCAIM is co-funded by the European Union under Grant Agreement 101100633., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication

Empowering cancer research in Europe: the EUCAIM cancer imaging infrastructure

  • Martí Bonmatí, Luis
  • Blanquer, Ignacio
  • Tsiknakis, Manolis
  • Tsakou, Gianna
  • Martinez, Ricard
  • Capella Gutierrez, Salvador
  • Gelpi, Jose Luis
Artificial intelligence (AI) is a powerful technology with the potential to disrupt cancer detection, diagnosis and treatment. However, the development of new AI algorithms requires access to large and complex real-world datasets. Although such datasets are constantly being generated, access to them is limited by data fragmentation across numerous repositories and sites, heterogeneity, lack of annotations, and potential privacy issues. The European Cancer Imaging Initiative is a flagship of Europe’s Beating Cancer Plan, aiming to unlock the power of AI for cancer patients, clinicians, and researchers by establishing a federated European infrastructure for cancer images through the EUfunded EUropean Federation for CAncer IMages (EUCAIM) project. This infrastructure, called Cancer Image Europe, builds on the AI for Health Imaging network (AI4HI), established European Research Infrastructures (Euro-BioImaging, BBMRI-ERIC, EATRIS, ECRIN, and ELIXIR), and numerous related partners providing access to research tools, images, and related clinical, pathology and molecular data. The infrastructure targets clinicians, researchers, and innovators by providing the means to develop and validate dataintensive AI-based and other IT-enabled clinical decision-making systems supporting precision medicine. Common data models, including a linking hyperontology, quality standards, compliance with the FAIR (Findability, Accessibility, Interoperability and Reusability) principles, data annotation, curation and anonymization services are provided to ensure data quality and interoperability, consistency and privacy. In summer 2024, the EUCAIM project released the first prototype of an EU-wide infrastructure, with a comprehensive dashboard integrating applications for dataset discovery, federated search, data access request, metadata harvesting, annotation, secure processing environments and federated processing, EUCAIM is co-funded by the European Union under Grant Agreement 101100633. Views and opinions expressed are, however, those of the author(s) only and do not necessarily reflect those of the European Union or the European Commission. Neither the European Union nor the granting authority can be held responsible for them., Peer Reviewed, "Article signat per 19 autors/es: Luis Martí-Bonmatí, Ignacio Blanquer, Manolis Tsiknakis, Gianna Tsakou, Ricard Martinez, Salvador Capella-Gutierrez, Sara Zullino, Janos Meszaros, Esther E. Bron, Jose Luis Gelpi, Katrine Riklund, Linda Chaabane, Heinz-Peter Schlemmer, Mario Aznar, Patricia Serrano Candelas, Peter Gordebeke, Monika Hierath, the EUCAIM Consortium & European Society of Radiology", Postprint (published version)